NCT04838145View on ClinicalTrials.gov

The Diabetes Virus Detection and Intervention Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

August 30, 2018

Primary Completion Date

October 25, 2020

Study Completion Date

October 25, 2020

Conditions
Type1 Diabetes MellitusEnterovirus
Interventions
DRUG

Ribavirin + Pleconaril

Randomized to treatment with study drugs (ribavirin and pleconaril)

DRUG

Placebos

Randomized to treatment with placebo

Trial Locations (1)

0514

Pediatric department, Oslo University Hospital, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER

NCT04838145 - The Diabetes Virus Detection and Intervention Trial | Biotech Hunter | Biotech Hunter